This clinical-stage biotech focused on precision medicines reported significant insider selling, according to recent SEC filings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback